123 related articles for article (PubMed ID: 30810340)
1. Clinicopathological and prognostic significance of octamer-binding transcription factor 4 in patients with gastric cancer: a systematic review and meta-analysis.
Wei Y; Liu H; Wang C; Zhang W; Wen X; Long H; Xu Z; Guo H; Liu Y; Wei D; Qiu C; Li G; Sun Z
Biomark Med; 2019 Feb; 13(3):219-234. PubMed ID: 30810340
[TBL] [Abstract][Full Text] [Related]
2. Oct4, a novel marker for human gastric cancer.
Chen Z; Xu WR; Qian H; Zhu W; Bu XF; Wang S; Yan YM; Mao F; Gu HB; Cao HL; Xu XJ
J Surg Oncol; 2009 Jun; 99(7):414-9. PubMed ID: 19347886
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of putative markers of cancer stem cells in gastric cancer: A retrospective cohort study.
Chen XL; Chen XZ; Wang YG; He D; Lu ZH; Liu K; Zhang WH; Wang W; Li CC; Xue L; Zhao LY; Yang K; Liu JP; Zhou ZG; Hu JK; Mo XM
Oncotarget; 2016 Sep; 7(38):62049-62069. PubMed ID: 27557490
[TBL] [Abstract][Full Text] [Related]
4. Coexpression of HMGA2 and Oct4 predicts an unfavorable prognosis in human gastric cancer.
Kong D; Su G; Zha L; Zhang H; Xiang J; Xu W; Tang Y; Wang Z
Med Oncol; 2014 Aug; 31(8):130. PubMed ID: 25037576
[TBL] [Abstract][Full Text] [Related]
5. Clinical value of octamer-binding transcription factor 4 as a prognostic marker in patients with digestive system cancers: A systematic review and meta-analysis.
Chen Z; Zhang L; Zhu Q; Wang X; Wu J; Wang X
J Gastroenterol Hepatol; 2017 Mar; 32(3):567-576. PubMed ID: 28320060
[TBL] [Abstract][Full Text] [Related]
6. Oct4 expression in gastric carcinoma: association with tumor proliferation, angiogenesis and survival.
El-Guindy DM; Wasfy RE; Abdel Ghafar MT; Ali DA; Elkady AM
J Egypt Natl Canc Inst; 2019 Nov; 31(1):3. PubMed ID: 32372156
[TBL] [Abstract][Full Text] [Related]
7. Heparanase mRNA and Protein Expression Correlates with Clinicopathologic Features of Gastric Cancer Patients: a Meta- analysis.
Li HL; Gu J; Wu JJ; Ma CL; Yang YL; Wang HP; Wang J; Wang Y; Chen C; Wu HY
Asian Pac J Cancer Prev; 2015; 16(18):8653-8. PubMed ID: 26745132
[TBL] [Abstract][Full Text] [Related]
8. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature.
Lei YY; Huang JY; Zhao QR; Jiang N; Xu HM; Wang ZN; Li HQ; Zhang SB; Sun Z
World J Surg Oncol; 2017 Mar; 15(1):68. PubMed ID: 28327158
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and prognostic significance of the RUNX3 expression in gastric cancer: a systematic review and meta-analysis.
Liu B; Han Y; Jiang L; Jiang D; Li W; Zhang T; Zu G; Zhang X
Int J Surg; 2018 May; 53():122-128. PubMed ID: 29578091
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer.
Cao GD; Xu XY; Zhang JW; Chen B; Xiong MM
PLoS One; 2016; 11(12):e0168085. PubMed ID: 28005970
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and prognostic significance of metastasis-associated in colon cancer-1 in gastric cancer: A meta-analysis.
Jin Y; Zhou K; Zhao W; Han R; Huo X; Yang F; Chen J
Int J Biol Markers; 2019 Mar; 34(1):27-32. PubMed ID: 30854927
[TBL] [Abstract][Full Text] [Related]
12. The Prognostic and Clinicopathologic Characteristics of OCT4 and Lung Cancer: A Meta-Analysis.
Li H; Wang L; Shi S; Xu Y; Dai X; Li H; Wang J; Zhang Q; Wang Y; Sun S; Li Y
Curr Mol Med; 2019; 19(1):54-75. PubMed ID: 30854966
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of octamer binding transcription factor 4 for patients with solid tumors: A meta-analysis.
Zhao X; Lu H; Sun Y; Liu L; Wang H
Medicine (Baltimore); 2020 Oct; 99(42):e22804. PubMed ID: 33080755
[TBL] [Abstract][Full Text] [Related]
14. [Expression of OCT4 in gastric cancer cell lines and its significance].
Huang ZJ; Wang R; Luo WY; Yi WC; Zeng YY; Luo Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 43(6):812-5. PubMed ID: 23387203
[TBL] [Abstract][Full Text] [Related]
15. Correlation of Cancer Stem-Cell Markers OCT4, SOX2, and NANOG with Clinicopathological Features and Prognosis in Operative Patients with Rectal Cancer.
You L; Guo X; Huang Y
Yonsei Med J; 2018 Jan; 59(1):35-42. PubMed ID: 29214774
[TBL] [Abstract][Full Text] [Related]
16. CD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: a systematic review and meta-analysis.
Yiming L; Yunshan G; Bo M; Yu Z; Tao W; Gengfang L; Dexian F; Shiqian C; Jianli J; Juan T; Zhinan C
Oncotarget; 2015 Dec; 6(39):42019-27. PubMed ID: 26503471
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of NOTCH1 and OCT4 in gastric carcinoma.
Ibrahim DA; Elsebai EA; Fayed A; Abdelrahman AE
Indian J Pathol Microbiol; 2022; 65(2):328-335. PubMed ID: 35435367
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and prognostic significance of OCT4 in patients with hepatocellular carcinoma: a meta-analysis.
Liang C; Xu Y; Ge H; Li G; Wu J
Onco Targets Ther; 2018; 11():47-57. PubMed ID: 29317833
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and prognostic significance of FoxM1 in gastric cancer: A meta-analysis.
Jiang D; Jiang L; Liu B; Huang H; Li W; Zhang T; Zu G; Zhang X
Int J Surg; 2017 Dec; 48():38-44. PubMed ID: 29017864
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of OCT4 in colorectal cancer: analysis using immunohistochemistry and bioinformatics validation.
Fang W; Ni M; Zhang M; Chen H
Biomark Med; 2020 Oct; 14(15):1473-1484. PubMed ID: 33185466
[No Abstract] [Full Text] [Related]
[Next] [New Search]
